Ventas, Inc. $VTR Shares Purchased by Rockefeller Capital Management L.P.

Posted by George Bondi on Jun 29th, 2026

Rockefeller Capital Management L.P. boosted its stake in Ventas, Inc. (NYSE:VTR – Free Report) by 38.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 36,893 shares of the real estate investment trust’s stock after buying an additional 10,273 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Ventas were worth $2,855,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. NewEdge Advisors LLC grew its stake in Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after buying an additional 7,097 shares during the last quarter. Empowered Funds LLC grew its position in shares of Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after acquiring an additional 536 shares during the last quarter. Woodline Partners LP increased its holdings in shares of Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after acquiring an additional 11,739 shares during the period. Focus Partners Wealth increased its holdings in shares of Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL purchased a new stake in Ventas in the 2nd quarter valued at $805,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Price Performance

VTR stock opened at $89.06 on Monday. The firm has a 50 day moving average of $85.21 and a 200-day moving average of $82.80. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The company has a market cap of $43.30 billion, a price-to-earnings ratio of 161.92, a PEG ratio of 1.91 and a beta of 0.71.

Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the company earned $0.84 EPS. The business’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts expect that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.3%. Ventas’s dividend payout ratio is 378.18%.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Jefferies Financial Group increased their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. KeyCorp upped their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Scotiabank decreased their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Raymond James Financial began coverage on shares of Ventas in a research note on Tuesday, June 16th. They set an “outperform” rating and a $94.00 target price for the company. Finally, UBS Group upped their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $96.00.

View Our Latest Research Report on VTR

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.